• 1
    Leblanc M, Pichette V, Geadah D, Ouimet D: Folic acid and pyridoxal-5′-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation. J Ren Nutr 10:196201, 2000
  • 2
    Descombes E, Hanck AB, Fellay G: Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43:13191328, 1993
  • 3
    Foque D, Vennegoor M, Ter Wee P, Wanner C, Basci A: EBPG Guideline on Nutrition. Nephrol Dial Transplant 22(Suppl 2):ii45ii87, 2007
  • 4
    Wooley JA: Characteristics of thiamin and its relevance to the management of heart failure [Review] [31 refs]. Nutr Clin Pract 23:487493, 2008
  • 5
    Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin D12, Pantothenic Acid, Biotin and Choline. 1998. The National Academies
  • 6
    Porrini M, Simonetti P, Ciappellano S, et al.: Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency. Int J Vitam Nutr Res 59:304308, 1989
  • 7
    Ramirez G, Chen M, Boyce HW Jr, et al.: Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation. Kidney Int 30:99106, 1986a
  • 8
    Blumberg A, Hanck A, Sander G: Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 20:244250, 1983
  • 9
    Frank T, Czeche K, Bitsch R, Stein G: Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation. Int J Vitam Nutr Res 70:159166, 2000
  • 10
    Descombes E, Boulat O, Perriard F, Fellay G: Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation. Artif Organs 24:773778, 2000
  • 11
    Heinz J, Domrose U, Westphal S, Luley C, Neumann KH, Dierkes J: Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology 13:384389, 2008
  • 12
    Ramirez G, Chen M, Boyce HW Jr, et al.: The plasma and red cell vitamin B levels of chronic hemodialysis patients: a longitudinal study. Nephron 42:4146, 1986b
  • 13
    Descombes E, Dessibourg CA, Fellay G: Acute enceaphalopathy due to thiamine deficiciency (Wenicke's encephalopathy) in a chronic hemodialyzed patient; a case report. Clin Nephrol 35:171175, 1991
  • 14
    Ihara M, Ito T, Yanagihara C, Nishimura Y: Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature [Review] [13 refs]. Clin Neurol Neurosurg 101:118121, 1999
  • 15
    Hung SC, Hung SH, Tarng DC, Yang WC, Huang TP: Chorea induced by thiamine deficiency in hemodialysis patients. Am J Kidney Dis 37:427430, 2001a
  • 16
    Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP: Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 38:941947, 2001b
  • 17
    Coveney N, Polkinghorne KR, Linehan L, Corradini A, Kerr PG: Water-soluble vitamin levels in extended hours hemodialysis. Hemodial Int, International Symposium on Home Hemodialysis 15:3038, 2011
  • 18
    Fouque D, Vennegoor M, ter Wee P, et al.: EBPG guideline on nutrition. Nephrol Dial Transplant 22(Suppl 2):ii4587, 2007
  • 19
    K/DOQI workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45(4 Suppl 3):S1S153, 2005
  • 20
    Kannampuzha J, Donnelly SM, McFarlane PA, et al.: Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis. J Ren Nutr 20:199208, 2010
  • 21
    Kastelein JJ, Bots ML: Statin therapy with ezetimibe or niacin in high-risk patients. N Engl J Med 361:21802183, 2009
  • 22
    Brown BG, Zhao XQ, Chait A et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.[Summary for patients in Curr Cardiol Rep. 2002 Nov;4(6):486; PMID: 12379170]. N Engl J Med 345:15831592, 2001
  • 23
    Grundy SM, Vega GL, McGovern ME, et al.: Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med 162:15681576, 2002
  • 24
    Eto N, Miyata Y, Ohno H, Yamashita T: Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant 20:13781384, 2005
  • 25
    ller D, Mehling H, Otto B, et al.: Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J Am Soc Nephrol 2:12491254, 2007
  • 26
    Takahashi Y, Tanaka A, Nakamura T, et al.: Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65:10991104, 2004
  • 27
    Rutkowski P, Slominska EM, Wolyniec W, et al.: Nicotinamide metabolites accumulate in the tissues of uremic rats. J Ren Nutr 18:5659, 2008
  • 28
    Slominska EM, Smolenski RT, Osborne F, Swierczynski J, Yacoub MH: The effect of N-methyl-2-pyridone-5-carboxamide–A nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells. Nucleosides Nucleotides Nucleic Acids 24:259262, 2005
  • 29
    Slominska EM, Smolenski RT, Szolkiewicz M, et al.: Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 231:8388, 2002
  • 30
    Kopple JD, Swendseid ME: Vitamin nutrition in patients undergoing maintenance hemodialysis. [Review] [42 refs]. Kidney Int Suppl 2:7984, 1975
  • 31
    Linder MC: Nutrition and metabolism of vitamins. In: Linder MC (ed). Nutritional Biochemistry and Metabolism with Clinical Applications, 1st ed. New York, New York: Elsevier Science Publishing Company, Inc., 1985:69132
  • 32
    Hellmann H, Mooney S: Vitamin B6: a molecule for human health? Molecules 15:442459, 2010
  • 33
    Kakuta T, Tanaka R, Satoh Y, et al.: Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats. Kidney Int 68:13261336, 2005
  • 34
    Nakamura S, Niwa T: Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol 16:144150, 2005
  • 35
    Selhub J, Miller JW: The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131138, 1992
  • 36
    Miller JW, Nadeau MR, Smith D, Selhub J: Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59:10331039, 1994
  • 37
    Institute of Medicine: Dietary Reference Intakes: Vitamins. http://www iomedu/~/media/Files/Activity%20Files/Nutrition/DRIs/DRI_Vitamins ashx (last accessed December 03, 2010) [serial online] 2001
  • 38
    Hathcock JN: Vitamins and minerals: efficacy and safety. Am J Clin Nutr 66:427437, 1997
  • 39
    Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 49:3162, 1998
  • 40
    Malouf R, Grimley EJ: The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 4:CD004393, 2003
  • 41
    Kasama R, Koch T, Canals-Navas C, Pitone JM: Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature. Am J Kidney Dis 27:680686, 1996
  • 42
    Ross EA, Shah GM, Reynolds RD, Sabo A, Pichon M: Vitamin B6 requirements of patients on chronic peritoneal dialysis. Kidney Int 36:702706, 1989
  • 43
    Mydlik M, Derzsiova K, Svac J, Dlhopolcek P, Zemberova E: Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 22:784788, 1998
  • 44
    Mydlik M, Derzsiova K: Erythrocyte vitamins B1, B2 and B6 and erythropoietin. Am J Nephrol 13:464466, 1993
  • 45
    Okada H, Moriwaki K, Kanno Y, et al.: Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin. Nephrol Dial Transplant 15:14101413, 2000
  • 46
    Mydlik M, Derzsiova K, Zemberova E: Metabolism of vitamin B6 and its requirement in chronic renal failure. Kidney Int Suppl 62:S56S59, 1997
  • 47
    Marangella M: Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness. Nephrol Dial Transplant 14:301303, 1999
  • 48
    Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H: Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 20:4249, 1992
  • 49
    Nascimento MM, Suliman ME, Murayama Y, et al.: Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study. J Ren Nutr 16:119124, 2006
  • 50
    Moriwaki K, Kanno Y, Nakamoto H, Okada H, Suzuki H: Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis. Adv Perit Dial 16:308312, 2000
  • 51
    de Koning L, Hu FB: Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit? Circulation 121:13791381, 2010
  • 52
    Keipert JA: Oral use of biotin in seborrhoeic dermatitis of infancy: a controlled trial. Med J Aust 1:584585, 1976
  • 53
    Institute of Medicine: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Viatmin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998). (last accessed December 16, 2010) [serial online] 378379, 1998
  • 54
    Yatzidis H, Koutsicos D, Agroyannis B, Papastephanidis C, Francos-Plemenos M, Delatola Z: Biotin in the management of uremic neurologic disorders. Nephron 36:183186, 1984
  • 55
    Jung U, Helbich-Endermann M, Bitsch R, Schneider S, Stein G: Are patients with chronic renal failure (CRF) deficient in biotin and is regular biotin supplementation required? Z Ernahrungswiss 37:363367, 1998
  • 56
    Albarracin C, Fuqua B, Geohas J, Juturu V, Finch MR, Komorowski JR: Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial. J Cardiometab Syndr 2:9197, 2007
  • 57
    Geohas J, Daly A, Juturu V, Finch M, Komorowski JR: Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci 333:145153, 2007
  • 58
    Albarracin CA, Fuqua BC, Evans JL, Goldfine ID: Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev 24:4151, 2008
  • 59
    Pawlowski A, Kostanecki W: Effect of biotin on hair roots and sebum excretion in women with diffuse alopecia. Pol Med J 5:447452, 1966
  • 60
    Livaniou E, Evangelatos GP, Ithakissios DS, Yatzidis H, Koutsicos DC: Serum biotin levels in patients undergoing chronic hemodialysis. Nephron 46:331332, 1987
  • 61
    Schaefer RM, Kosch M, Teschner M: Folate metabolism in renal failure. Nephrol Dial Transplant 17(Suppl 5):2427, 2002
  • 62
    United States Department of Agriculture: Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 18. Nutrient lists. [serial online] 2010 (last accessed January 2013)
  • 63
    Fischbach FT, Dunning MB (eds). Vitamins in human nutrition. In: A Manual of Laboratory and Diagnostic Tests. Philadelphia, PA: Lippincott Williams & Wilkins, 2008: 1193
  • 64
    Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J: Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 131:32773280, 2001
  • 65
    Institute of Medicine: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Viatmin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998). php?record_id=6015&page=201 (last accessed December 16, 2010) [serial online] 1998;201
  • 66
    Malouf M, Grimley EJ, Areosa SA: Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 4:CD004514, 2003
  • 67
    Public Health Agency of Canada: Evaluation of Food Fortification with Folic Acid for the Primary Prevention of Neural Tube Defects. http://www.phac-aspcgcca/publicat/faaf/chap3-eng.php (last accessed December 06, 2010) [serial online] 2004
  • 68
    Berry RJ, Bailey L, Mulinare J, Bower C: Fortification of flour with folic acid. Food Nutr Bull 31:S22S35, 2010
  • 69
    Food Safety Auhority of Ireland: Report of the National Committee on Folic Acid Food Fortification. ISBN 1-9004465-43-9. 2006
  • 70
    Institute of Medicine: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Viatmin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998). (last accessed December 16, 2010) [serial online]261263, 1998
  • 71
    Polonsky TS, McClelland RL, Jorgensen NW, et al.: Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303:16101616, 2010
  • 72
    Malouf R, Grimley EJ: Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 3:CD004514, 2008a
  • 73
    Taylor MJ, Carney SM, Goodwin GM, Geddes JR: Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 18:251256, 2004
  • 74
    Lee EY, Kim JS, Lee HJ, et al.: Do dialysis patients need extra folate supplementation? Adv Perit Dial 15:247250, 1999
  • 75
    Billion S, Tribout B, Cadet E, et al.: Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12. Nephrol Dial Transplant 17:455461, 2002
  • 76
    Reference values for plasma homocysteine and folate levels in Korean adults. [serial online] 2007 (last accessed January 2013)
  • 77
    Stoll C, Alembik Y, Dott B: Are the recommendations on the prevention of neural tube defects working? Eur J Med Genet 49:461465, 2006
  • 78
    De Vecchi AF, Bamonti-Catena F, Finazzi S, et al.: Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients. Perit Dial Int 20:169173, 2000
  • 79
    Goto S, Fujii H, Kim JI, Fukagawa M: Homocysteine and folic acid levels in hemodialysis patients treated with sevelamer hydrochloride. Clin Nephrol 73:420425, 2010
  • 80
    Food Standards Authority UK: Folic acid fortification. http://www.eatwell.govuk/healthissues/factsbehindissues/folicacid/#elem377019 last accessed December 08, 2010 [serial online] 2010
  • 81
    Randaccio L, Geremia S, Demitri N, Wuerges J: Vitamin B12: unique metalorganic compounds and the most complex vitamins. Molecules (Basel, Switzerland) 15:32283259, 2010
  • 82
    CPhA: Vitamin B12 (cyanocobalamin-hydroxocobalamin). Compendium of Pharmaceuticals and Specialties. 2011
  • 83
    Vogiatzoglou A, Smith AD, Nurk E, et al.: Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine Study. Am J Clin Nutr 89:10781087, 2009
  • 84
    Ganong WF: Vitamin B12 (Cyanocobalamin). Toronto: McGraw-Hills Companies; 2005;312,313,315,477,496,623
  • 85
    Allen LH: How common is vitamin B-12 deficiency ? Am J Clin Nutr 89:s693s696, 2009
  • 86
    Nava-Ocampo A, Pastrak A, Cruz T, Koren G: Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats. Clin Exp Pharmacol Physiol 32:1318, 2005
  • 87
    Vidal-Alaball J, Butler CC, Cannings-John R, et al.: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev (Online) 3:CD004655, 2005
  • 88
    Davey GK, Spencer E, Appleby PN, Allen NE, Knox KH, Key TJ: EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK. Public Health Nutr 6:259269, 2003
  • 89
    Campbell AK, Miller JW, Green R, Haan MN, Allen LH: Plasma vitamin B-12 concentrations in an elderly Latino population are predicted by serum gastrin concentrations and crystalline vitamin B-12 intake. J Nutr 133:27702776, 2003
  • 90
    McColl KEL: Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol 104:s5s9, 2009
  • 91
    Matteini AM, Walston JD, Bandeen-Roche K, et al.: Transcobalamin-II variants, decreased vitamin B12 availability and increased risk of frailty. J Nutr Health Aging 14:7377, 2010
  • 92
    Sturtzel B, Dietrich A, Wagner KH, Gisinger C, Elmadfa I: The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber. J Nutr Health Aging 14:219223, 2010
  • 93
    IOM: Dietary Reference Intakes - Vitamins. 2001. Washington D.C., The National Academies of Science
  • 94
    Kwan LL, Bermudez OI, Tucker KL: Low vitamin B-12 intake and status are more prevalent in Hispanic older adults of Caribbean origin than in neighborhood-matched non-Hispanic whites. J Nutr 132:20592064, 2002
  • 95
    Green R, Miller JW: Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 43:10481051, 2005
  • 96
    Mudd SH, Finkelstein JD, Refsum H, et al.: Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 20:17041706, 2000
  • 97
    MartÃ−-Carvajal AJ, Solà I, Lathyris D, Salanti G: Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (Online) 4:CD006612, 2009
  • 98
    McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111128, 1969
  • 99
    Boushey CJ, Beresford S, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:10491057, 1995
  • 100
    McCaddon a, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 12:309313, 2001
  • 101
    Smith AD, Refsum H: Vitamin B-12 and cognition in the elderly. Am J Clin Nutr 89:707S711S, 2009
  • 102
    Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Nutr 60:211, 1994
  • 103
    Collin SM, Metcalfe C, Refsum H, et al.: Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis. Cancer Epidemiol Biomarkers Prev 19:16321642, 2010
  • 104
    Lee M, Hong KS, Chang SC, Saver JL: Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 41:12051212, 2010
  • 105
    Miller ER, Juraschek S, Pastor-Barriuso R, Bazzano L, Appel LJ, Guallar E: Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 106:517527, 2010
  • 106
    Clarke R, Halsey J, Lewington S, et al.: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170:16221631, 2010
  • 107
    Lonn E, Yusuf S, Arnold MJ, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:15671577, 2006
  • 108
    Saposnik G, Ray JG, Sheridan P, Mcqueen M, Lonn E, Investigators H: Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability: Additional Findings From the HOPE 2 Trial. Stroke 40:13651372, 2009
  • 109
    The VITATOPS Trial Study Group: Articles B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9:855865, 2010
  • 110
    Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group: Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 303:24862494, 2010
  • 111
    Ellinson M, Thomas J, Patterson A: A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 17:371383, 2004
  • 112
    Aisen PS, Schneider LS, Sano M, et al.: High-dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease. JAMA 300:17741783, 2008
  • 113
    Eussen SJ, de Groot LC, Joosten LW, et al.: Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 84:361370, 2006
  • 114
    Ford AH, Flicker L, Alfonso H, et al.: Vitamins B12, B6, and folic acid for cognition in older men. Neurology 75:15401547, 2010
  • 115
    Kang JH, Cook N, Manson JA, Buring JE, Albert CM, Grodstein F: A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 88:16021610, 2008
  • 116
    McMahon J, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM: A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354:27642772, 2006
  • 117
    Stott DJ, MacIntosh G, Lowe GDO, et al.: Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 82:13201326, 2005
  • 118
    Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC: Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 29:22042214, 2007
  • 119
    van Uffelen JGZ, Chinapaw MJM, van Mechelen W, Hopman-Rock M: Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br J Sports Med 42:344351, 2008
  • 120
    Malouf R, Areosa S: Vitamin B12 for cognition. Cochrane Database Syst Rev (Online) 3:CD004394, 2003
  • 121
    Heinz J, Kropf S, Domröse U, et al.: B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation 121:14321438, 2010
  • 122
    Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlöf I, Kallner A: Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration. Scand J Urol Nephrol 42:7480, 2008
  • 123
    Heinz J, Kropf S, Luley C, Dierkes J: Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis 54:478489, 2009
  • 124
    Clement L, Boylan M, Miller VG, Rockwell M, Allred K: Serum levels of folate and cobalamin are lower in depressed than in nondepressed hemodialysis subjects. J Ren Nutr 17:343349, 2007
  • 125
    Hoffer J: Editorial: Renal Failure, homocysteine and the pharmacology of vitamin B12. Metabolism 51:399402, 2002
  • 126
    Hoffer LJ, Elian KM: Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Clin Invest Med 27:1013, 2004
  • 127
    Hoffer LJ, Djahangirian O, Bourgouin PE, Eid J, Saboohi F: Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease. Metabolism 54:13621367, 2005
  • 128
    Brady CB, Gaziano JM, Cxypoliski RA, et al.: Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis 54:440449, 2009
  • 129
    Jamison RL, Hartigan P, Kaufman JS, et al.: Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298:11631170, 2007
  • 130
    Mann JFE, Sheridan P, McQueen MJ, et al.: Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease–results of the renal Hope-2 study. Nephrol Dial Transplant 23:645653, 2008a
  • 131
    Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF: The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord 8:24, 2008
  • 132
    Carmel R: Efficacy and safety of fortification and supplementation with vitamin B12: biochemical and physiological effects. Food Nutr Bull 29:S177S187, 2008
  • 133
    Milton K: Nutritional characteristics of wild primate foods: do the diets of our closest living relatives have lessons for us? Nutrition 15:488498, 1999
  • 134
    Bartholomew M: James Lind's Treatise of the Scurvy (1753). Postgrad Med J 78:695696, 2002
  • 135
    Deicher R, Ziai F, Bieglmayer C, Schillinger M, Horl WH: Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 16:18111818, 2005
  • 136
    Food and Nutrition Board and Panel on Deitary Antioxidants and Related Compounds: Vitamin C, in: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. 95185. 2000. Washington DC, National Academy Press
  • 137
    Levine M, Wang Y, Padayatty SJ, Morrow J: A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:98429846, 2001
  • 138
    Pauling L. Vitamin C the Common Cold and the Flu. New York: W.H.Freeman & Co Ltd, 1977
  • 139
    Levine M, Conry-Cantilena C, Wang Y, et al.: Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93:37043709, 1996
  • 140
    Canavese C, Petrarulo M, Massarenti P, et al.: Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 45:540549, 2005
  • 141
    Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 57:787S797S, 1993
  • 142
    Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:2333, 2002
  • 143
    Long CL, Maull KI, Krishnan RS, et al.: Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 109:144148, 2003
  • 144
    Douglas RM, Hemila H, Chalker E, Treacy B: Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 3:CD000980, 2007
  • 145
    Takahashi N, Morimoto S, Okigaki M, Seo M, Someya K, Morita R et al.: Decrease plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrology Dialysis Transplantation 26:12521257, 2011.
  • 146
    Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R: Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res 67:262266, 1997
  • 147
    Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ: Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant 23:20582063, 2008
  • 148
    Lee EJ, Myint CC, Tay ME, Yusuf N, Ong CN: Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 17:219222, 2001
  • 149
    Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P: High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton) 13:1722, 2008
  • 150
    Morena M, Cristol JP, Bosc JY, et al.: Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 17:422427, 2002
  • 151
    Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD: Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis 18:8490, 1991
  • 152 [serial online] 2010 (last accessed January 2013)
  • 153
    Mydlik M, Derzsiova K: Renal replacement therapy and secondary hyperoxalemia in chronic renal failure. Kidney Int Suppl 78:S304S307, 2001
  • 154
    Pru C, Eaton J, Kjellstrand C: Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 39:112116, 1985
  • 155
    Deved V, Poyah P, James MT, et al.: Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis 54:10891097, 2009
  • 156
    Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT: Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int 69:706714, 2006
  • 157
    Weissinger EM, Nguyen-Khoa T, Fumeron C, et al.: Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 6:9931000, 2006
  • 158
    Fang JC, Kinlay S, Beltrame J, et al.: Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359:11081113, 2002
  • 159
    Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA: A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 16:14481451, 2001
  • 160
    Deira J, Diego J, Martinez R, et al.: Comparative study of intravenous ascorbic acid versus low-dose desferroxamine in patients on hemodialysis with hyperferritinemia. J Nephrol 16:703709, 2003
  • 161
  • 162
  • 163
    Holden RM, Ki V, Ross Morton A, Clase CM: Fat-Soluble Vitamins in Advanced CKD⁄ESKD: a review. Semin Dial 25:334343, 2012
  • 164
    Skoupy S, dinger M, Veitl M, et al.: Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. J Am Soc Nephrol 13:13311337, 2002
  • 165
    Seabrook GR, Karp D, Schmitt DD, Bandyk DF, Towne JB: An outpatient anticoagulation protocol managed by a vascular nurse-clinician. Am J Surg 160:501505, 1990
  • 166
    University of Washington Department of Laboratory Medicine ID: Serum and RBC folate. HTML [serial online] 2010
  • 167
    Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ: Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000. Am J Clin Nutr. 82:442450, 2005.
  • 168
    Biesalski HK: Parenteral ascorbic acid in haemodialysis patients. Curr Opin Clin Nutr Metab Care 11:741746, 2008
  • 169
    Hultqvist M, Hegbrant J, Nilsson-Thorell C, et al.: Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 47:3746, 1997
  • 170
    Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41:11351138, 1995